Human papillomavirus vaccine use among adolescent girls and young adult women: An analysis of the 2007 California health interview survey

Journal of Women's Health

Volumn 21, Issue 6, 2012, Pages 656-665

  Tiro, Jasmin A ^a   Tsui, Jennifer ^b   Bauer, Heidi M ^c   Yamada, Eileen ^d   Kobrin, Sarah ^e   Breen, Nancy ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; EDUCATION; FEMALE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PARENT; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; SCHOOL CHILD; SEXUAL BEHAVIOR; SEXUALITY; UNITED STATES;

ADOLESCENT; ADULT; CALIFORNIA; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH BEHAVIOR; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; VACCINATION; YOUNG ADULT;

EID: 84862162547     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3284     Document Type: Article

References (56)

1. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7-28. (Pubitemid 46148088)
2. American College of Obstetricians and Gynecologists Committee on Adolescent Health Care and The ACOG Working Group on Immunization. Human papillomavirus vaccination. Obstet Gynecol 2006;108:699-705.
3. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-2):1-24.
4. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 2008;111:1103-1110. (Pubitemid 351620344)
5. Jaspan DM, Dunton CJ, Cook TL. Acceptance of human papillomavirus vaccine by gynecologists in an urban setting. J Low Genit Tract Dis 2008;12:118-121. (Pubitemid 351457917)
6. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008;43:239-245.
7. Jain N, Stokley S, Yankey D. Vaccination coverage among adolescents aged 13-17 years, United States, 2007. MMWR 2008;57:1100-1103.
8. Conroy K, Rosenthal SL, Zimet GD, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and selfreported barriers to vaccination. J Womens Health 2009;18: 1679-1686.
9. Stokley S, Dorell C, Yankey D. National, state, and local area vaccination coverage among adolescents aged 13-17 years United States, 2008. MMWR 2009;58:997-1001.
10. Chao C, Slezak JM, Coleman KJ, Jacobsen SJ. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009;99:1137-1142.
11. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. J Adolesc Health 2009;45:453-462.
12. Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 2009;19:531-538.
13. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: Uptake and intentions. J Adolesc Health 2009;45:528-531.
14. Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiations in an area with elevated rates of cervical cancer. J Adolesc Health 2009;45:430-437.
15. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009;69:475-480.
16. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010;171:357-367.
17. Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010;28:989-995.
18. Pruitt SL, Schootman M. Geographic disparity, area-level poverty and human papillomavirus (HPV) vaccination among girls in 6 U.S. states. Am J Prev Med 2010;38:525-533.
19. Mathur MB, Mathur VS, Reichling DB. Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. J Pediatr Health Care 2010;24:14-24.
20. Dorell C, Stokley S, Yankey D, Cohn AC. National, state, and local area vaccination coverage among adolescents aged 13-17 years United States, 2009. MMWR 2010;59:1018-1023.
21. Allen JD, Mohllajee AP, Shelton RC, Othus MK, Fontenot HB, Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009;48:420-425.
22. Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 2009;48:426-431.
23. Schiller JS, Euler GL. NCHS health E-Stats: Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. Available at www cdc gov/nchs/data/hestat/vaccine-coverage pdf
24. Licht AS, Murphy JM, Hyland AJ, Fix BV, Hawk LW, Mahoney MC. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sex Transm Infect 2010;86:74-78.
25. Roberts ME, Gerrard M, Reimer R, Gibbons FX. Motherdaughter communication and human papillomavirus vaccine uptake by college students. Pediatrics 2010;125: 982-989.
26. Anhang Price R, Tiro JA, Saraiya M, Meissner H, Breen N. Use of human papillomavirus vaccines among young adult women in the United States: An analysis of the 2008 National Health Interview Survey. Cancer 2011;117:5560-5568.
27. Tiro JA, Saraiya M, Jain N, et al. HPV and cervical cancer behavioral surveillance in the United States. Cancer 2008;113(Suppl 10):3013-1330.
28. Freeman HP, Wingrove BK. Excess cervical cancer mortality: A marker for low access to health care in poor communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005. Report No. NIH Pub. No. 05-5282.
29. Hewitt M, Devesa SS, Breen N. Cervical cancer screening among U.S. women: Analyses of the 2000 National Health Interview Survey. Prev Med 2004;39:270-278. (Pubitemid 38834016)
30. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 2004;101:1051-1057. (Pubitemid 39100440)
31. Bosch FX, de SS. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007;23: 213-227. (Pubitemid 47015785)
32. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer 2007;109(Suppl 2):348-358. (Pubitemid 46106219)
33. Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States: Results from the 2005 National Health Interview Survey. Cancer 2010;116:4872-4881.
34. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2006 incidence and mortality. Web-based report. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, 2010.
35. Coughlin SS, Richards TB, Nasseri K, et al. Cervical cancer incidence in the United States in the US-Mexico border region, 1998-2003. Cancer 2008;113(Suppl 10):2964-2973.
36. Bates JH, Hofer BM, Parikh-Patel A. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990-2004. Cancer 2008;113(Suppl 10):2955-2963.
37. Hofer BM, Bates JH, McCusker ME, Nasseri K, Cress RD, Snipes KP. Cervical cancer in California, 2008. Sacramento, CA: California Department of Public Health, Cancer Surveillance Section, 2008.
38. Taylor VM, Nguyen TT, Jackson JC, McPhee SJ. Cervical cancer control research in Vietnamese American communities. Cancer Epidemiol Biomarkers Prev 2008;17:2924-2930.
39. Maxwell AE, Bastani R, Vida P, Warda US. Results of a randomized trial to increase breast and cervical cancer screening among Filipino American women. Prev Med 2003; 37:102-109. (Pubitemid 36802374)
40. U.S. Food and Drug Administration. FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. Available at www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html
41. University of California Los Angeles Center for Health Policy Research. California Health Interview Survey (CHIS) 2007 Methodology Series: Report 4 Response rates. Los Angeles, CA: UCLA Center for Health Policy Research, 2009.
42. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med 2007;45:107-114. (Pubitemid 47348081)
43. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus (HPV) and cervical cancer? Cancer Epidemiol Biomarkers Prev 2007;16: 288-294. (Pubitemid 46383348)
44. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 2000.
45. Szilagyi PG, Rand CM, McLaurin J et al. Delivering adolescent vaccinations in the medical home: A new era? Pediatrics 2008;121(Suppl 1):S15-S24.
46. California Department of Health Care Services. HPV vaccine update, in Medi-Cal update part 2 Billing and policy. Bulletin 399, 2007.
47. American College of Obstetricians and Gynecologists. Cervical cytology screening. ACOG practice bulletin No.109. Obstet Gynecol 2009;114:1409-1420.
48. U.S. Preventive Services Task Force. Screening for cervical cancer: Recommendations and rationale, 2006. Available at www.ahrq.gov/clinic/3rduspstf/ cervcan/cervcanrr.htm
49. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010;60:99-119.
50. Hinman AR, Orenstein WA. Adult immunization: What can we learn from the childhood immunization program? Clin Infect Dis 2007;44:1532-1535. (Pubitemid 46871497)
51. Infectious Disease Society of America. Policy principles actions to strengthen adult and adolescent immunization coverage in the United States. Clin Infect Dis 2007;44:e104-e108.
52. Dorell C, Jain N, Yankey D. Validity of parent-reported vaccination status for adolescents aged 13-17 years: National Immunization Survey-Teen, 2008. Public Health Rep 2011;126(Suppl 2):60-69.
53. Centers for Disease Control and Prevention. 2007 Behavioral Risk Factor Surveillance System summary Data Quality Report, 2008.
54. Cantor D, Coa K, Crystal-Mansour S, Davis T, Dipko S, Sigman R. Health Information National Trends Survey (HINTS). 2007 final report, 2009.
55. Keeter S, Miller C, Kohut A, Groves R, Presser S. Consequences of reducing nonresponse in a large national telephone survey. Public Opin Q 2000;64:125-148.
56. Tourangeau R. Survey research and societal change. Annu Rev Psychol 2004;55:775-801.